...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Pfizer
5
Mar 11, 2024 07:39AM
3
Mar 11, 2024 10:20AM
3
Mar 12, 2024 08:12AM
3
Mar 12, 2024 01:45PM
6
Mar 12, 2024 02:38PM

narmac, Investment Banking Firms would do the IPO underwriting, and there are many.

 

Koo

7
Mar 12, 2024 04:21PM
Share
New Message
Please login to post a reply